big xt, page-43

From what I have been told the submission QRX presented was first class and according to my contacts FDA approval is very likely.

I have posted in the past that FDA is the only hurdle left which some poster with a self professing nic made a big deal out of but with investing in Biotech you have to be up front.

As for the share price Iam thinking $5 twelve months.

Still lots to happen European approval, role out of other products and licensing deals.

Good time to be holding.

Regards,